Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: A pre-post cluster randomized study

Clinical Microbiology and Infection

Volumn 20, Issue 10, 2014, Pages 1033-1039

  Launay, O ^a,b,c   Le Strat, Y ^d   Tosini, W ^e   Kara, L ^a,b,c   Quelet, S ^f   Levy S ^g   Danan, J ^a,b,c   Reveillon J ^a,b,c   Houdayer, J ^g   Bouvet, E ^e   Levy Bruhl D ^d   Doré, Véronique ^h   Porteret, Isabelle ^h   Sanchez, Ventzislava Petrov ^h   Bica, Setty Allam ^h   Brosson, ⁱ   Spenatto, ^j   Soula, ^k   Truchetet, ^l   Schmit, ^m   Gilg, ⁿ   Lapine, M ^o   Trepo, ^p   Vandemeulebroucke, ^q   Michau, ^r   Mulberg, ^s   Misery, ^t   Bonnet, ^u   Esnault, ^v   Courtieu, ^w   Cerfontaine, ^x   Launay, ^y   Le Strat, ^d   Tosini, ^e   Kara, ^y   Quelet, ^f   Levy ^g   Danan, ^y   Reveillon ^y   Houdayer, ^g   Bouvet, ^e   Levy Bruhl ^d   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c CIC Cochin Pasteur ^*  (France)

^d INSTITUT DE VEILLE SANITAIRE   (France)

^e BICHAT HOSPITAL   (France)

^f Direction de l'Action Sociale de l'Enfance et de la Sante Cellule Cohorte   (France)

^g Ctr Reg d'Info de Prev du Sida   (France)

^h CH de Troyes   (France)

ⁱ DGDSS de Nîmes   (France)

^j Serv Univ Psychiat l'Enfant l'A   (France)

^k CH Pontchaillou Rennes   (France)

^l CHR Metz   (France)

^m UNIVERSITY HOSPITAL OF STRASBOURG   (France)

ⁿ EDOUARD HERRIOT HOSPITAL   (France)

^o CH Georges Renon de Niort   (France)

^p HÔTEL DIEU   (France)

^q CH de Gonesse   (France)

^r CH de Saint Nazaire   (France)

^s Pasteur Hospital   (France)

^t CHU MORVAN   (France)

^u NANTES UNIVERSITY HOSPITAL   (France)

^v CH La Roche sur Yon   (France)

^w Centre de prophylaxie des MST de Besançon   (France)

^x Unité d'Action Sociale de Melun   (France)

^y CIC Cochin pasteur CIC1417   (France)

more..

Author keywords

Hepatitis B virus vaccine; Intervention study; Training; Vaccination strategies; Vaccine acceptability; Vaccine coverage

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; VACCINATION; ATTITUDE TO HEALTH; ECONOMICS; EDUCATION; FRANCE; MASS IMMUNIZATION; PATIENT COMPLIANCE; TRENDS;

HEPATITIS B VIRUS;

FEMALE; FRANCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MASS VACCINATION; PATIENT COMPLIANCE;

EID: 84913616074     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12689     Document Type: Article

References (20)

1. World Health Organization. Fact sheet N°204: hepatitis B. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/index.html [Accessed January 18, 2014].
2. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol 2010; 82: 546-555.
3. Institut de veille sanitaire. Prévalence des hépatites B et C en France en Available at: http://www.invs.sante.fr/publications/2006/prevalence:b_c/vhb_france:2004.pdf [accessed January 18, 2014].
4. Hepatitis B. Vaccines: WHO position paper-recommendations. Vaccine 2010; 28: 589-590.
5. Calendrier vaccinal 2007 - Avis du Haut conseil de la santé publique. 24 juillet 2007. Bull Epidemiol Hebd no. 31-32.
6. Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol 2002; 67: 440-443.
7. Antona D, Fonteneau L, Levy Bruhl D, et al. Couverture vaccinale des enfants et des adolescents en France: résultats des enquêtes menées en milieu scolaire, 2001-2004. Bull Epidemiol Hebd 2007; n 6: 45-49.
8. Denis F, Abitbol V, Aufrere A. évolution des stratégies vaccinales et couverture vaccinale contre l'hépatite B en France, pays de faible endémie. Med Mal Infect 2004; 34: 149-158.
9. Ministére de la santé. Mission d'expertise sur la politique de vaccination contre l'hépatite B en France. Available at: http://www. ladocumentationfrancaise.fr/rapports-publics/024000604/index.shtml [assessed January 14, 2014].
10. Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327-332.
11. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004; 63: 838-842.
12. Prévention de l'hépatite B auprés des personnes les plus exposées. Collection INPES "Repéres pour votre pratique". Available at: http:// www.inpes.sante.fr/CFESBases/catalogue/pdf/931.pdf [accessed January 18, 2014].
13. Julious SA. Sample Sizes for Clinical Trials. Boca Raton: CRC Press, 2009.
14. Yelland LN, Salter AB, Ryan P. Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol 2011; 174: 984-992.
15. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-706.
16. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964-974.
17. Gunn RA, Lee MA, Murray PJ, Gilchick RA, Margolis HS. Hepatitis B vaccination of men who have sex with men attending an urban STD clinic: impact of an ongoing vaccination program, 1998-2003. Sex Transm Dis 2007; 34: 663-668.
18. van Steenbergen JE. Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners. J Hepatol 2002; 37: 507-513.
19. Hollmeyer H, Hayden F, Mounts A, Buchholz U. Review: interventions to increase influenza vaccination among healthcare workers in hospitals. Influenza Other Respir Viruses 2013; 7: 604-21.
20. Heron L, Selnikova O, Moiseieva A, et al. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial. Vaccine 2007; 25: 2817-2822.